Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Operating Income 2006-2020 | GILD

Gilead Sciences annual/quarterly operating income history and growth rate from 2006 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Gilead Sciences operating income for the quarter ending June 30, 2020 was $-2.983B, a 222.76% decline year-over-year.
  • Gilead Sciences operating income for the twelve months ending June 30, 2020 was $-0.961B, a 111.39% decline year-over-year.
  • Gilead Sciences annual operating income for 2019 was $4.287B, a 47.72% decline from 2018.
  • Gilead Sciences annual operating income for 2018 was $8.2B, a 41.94% decline from 2017.
  • Gilead Sciences annual operating income for 2017 was $14.124B, a 19.9% decline from 2016.
  
Gilead Sciences Annual Operating Income
(Millions of US $)
2019 $4,287
2018 $8,200
2017 $14,124
2016 $17,633
2015 $22,193
2014 $15,265
2013 $4,524
2012 $4,010
2011 $3,790
2010 $3,962
2009 $3,529
2008 $2,679
2007 $2,165
2006 $-759
2005 $1,109
Gilead Sciences Quarterly Operating Income
(Millions of US $)
2020-06-30 $-2,983
2020-03-31 $2,402
2019-12-31 $1,093
2019-09-30 $-1,473
2019-06-30 $2,430
2019-03-31 $2,237
2018-12-31 $1,144
2018-09-30 $2,623
2018-06-30 $2,280
2018-03-31 $2,153
2017-12-31 $2,291
2017-09-30 $3,812
2017-06-30 $4,254
2017-03-31 $3,767
2016-12-31 $4,045
2016-09-30 $4,399
2016-06-30 $4,538
2016-03-31 $4,651
2015-12-31 $5,621
2015-09-30 $5,585
2015-06-30 $5,616
2015-03-31 $5,371
2014-12-31 $4,330
2014-09-30 $3,480
2014-06-30 $4,412
2014-03-31 $3,043
2013-12-31 $1,197
2013-09-30 $1,148
2013-06-30 $1,154
2013-03-31 $1,025
2012-12-31 $1,107
2012-09-30 $1,044
2012-06-30 $1,059
2012-03-31 $800
2011-12-31 $867
2011-09-30 $1,004
2011-06-30 $1,017
2011-03-31 $902
2010-12-31 $829
2010-09-30 $979
2010-06-30 $993
2010-03-31 $1,161
2009-12-31 $1,065
2009-09-30 $894
2009-06-30 $761
2009-03-31 $808
2008-12-31 $711
2008-09-30 $694
2008-06-30 $606
2008-03-31 $668
2007-12-31 $514
2007-09-30 $547
2007-06-30 $543
2007-03-31 $560
2006-12-31 $-1,553
2006-09-30 $58
2006-06-30 $365
2006-03-31 $372
2005-12-31 $360
2005-09-30 $248
2005-06-30 $277
2005-03-31 $223
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $86.306B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.998B 11.09
Amgen (AMGN) United States $141.574B 15.38
CSL (CSLLY) Australia $92.626B 0.00
Vertex Pharmaceuticals (VRTX) United States $70.548B 39.37
Regeneron Pharmaceuticals (REGN) United States $67.370B 24.91
Illumina (ILMN) United States $50.589B 58.43
Biogen (BIIB) United States $46.421B 7.94
Seattle Genetics (SGEN) United States $27.629B 0.00
Moderna (MRNA) United States $27.432B 0.00
Genmab (GMAB) Denmark $23.773B 19.56
Alexion Pharmaceuticals (ALXN) United States $22.527B 9.39
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.281B 0.00
Genmab (GNMSF) Denmark $21.968B 65.22
BioMarin Pharmaceutical (BMRN) United States $21.403B 155.29
Incyte (INCY) United States $20.606B 0.00
BeiGene (BGNE) Cayman Islands $19.054B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.852B 0.00
BioNTech SE (BNTX) Germany $15.637B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.061B 68.12
Horizon Therapeutics Public (HZNP) Ireland $14.999B 35.10
Exact Sciences (EXAS) United States $13.087B 0.00
Galapagos (GLPG) Belgium $12.406B 44.95
Sarepta Therapeutics (SRPT) United States $12.404B 0.00
QIAGEN (QGEN) Netherlands $11.028B 27.99
ARGENX SE-ADR (ARGX) Netherlands $10.912B 0.00
Bio-Techne Corp (TECH) United States $10.069B 69.69
Immunomedics (IMMU) United States $9.389B 0.00
Guardant Health (GH) United States $8.626B 0.00
Novavax (NVAX) United States $7.624B 0.00
Repligen (RGEN) United States $7.504B 119.11
Ascendis Pharma (ASND) Denmark $7.451B 0.00
Emergent Biosolutions (EBS) United States $6.857B 27.16
Exelixis (EXEL) United States $6.755B 24.56
Vir Biotechnology (VIR) United States $6.717B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.407B 198.50
SWEDISH ORP BIO (BIOVF) Sweden $6.375B 15.86
ACADIA Pharmaceuticals (ACAD) United States $6.285B 0.00
Mirati Therapeutics (MRTX) United States $5.861B 0.00
Acceleron Pharma (XLRN) United States $5.522B 0.00
MyoKardia (MYOK) United States $5.381B 0.00
Adaptive Biotechnologies (ADPT) United States $5.209B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.078B 0.00
Zai Lab (ZLAB) China $4.628B 0.00
NeoGenomics (NEO) United States $4.413B 1332.00
MorphoSys AG (MOR) Germany $4.282B 56.12
China Biologic Products (CBPO) China $4.175B 23.21
Blueprint Medicines (BPMC) United States $4.100B 0.00
Bluebird Bio (BLUE) United States $4.091B 0.00
Halozyme Therapeutics (HALO) United States $3.913B 0.00
Amicus Therapeutics (FOLD) United States $3.783B 0.00
Global Blood Therapeutics (GBT) United States $3.782B 0.00
Arena Pharmaceuticals (ARNA) United States $3.659B 0.00
Reata Pharmaceuticals (RETA) United States $3.434B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.417B 0.00
Denali Therapeutics (DNLI) United States $3.174B 0.00
Sorrento Therapeutics (SRNE) United States $3.004B 0.00
Insmed (INSM) United States $3.002B 0.00
Fate Therapeutics (FATE) United States $2.962B 0.00
Alkermes (ALKS) Ireland $2.960B 62.03
Principia Biopharma (PRNB) United States $2.900B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.644B 0.00
Amarin (AMRN) Ireland $2.552B 0.00
Twist Bioscience (TWST) United States $2.544B 0.00
Inovio Pharmaceuticals (INO) United States $2.303B 0.00
Editas Medicine (EDIT) United States $2.164B 0.00
Viela Bio (VIE) United States $1.959B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
UniQure (QURE) Netherlands $1.846B 0.00
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 60.74
Seres Therapeutics (MCRB) United States $1.797B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.762B 0.00
I-Mab (IMAB) China $1.675B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
Eidos Therapeutics (EIDX) United States $1.633B 0.00
Revance Therapeutics (RVNC) United States $1.623B 0.00
Cytokineticsorporated (CYTK) United States $1.545B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.466B 0.00
Zealand Pharma (ZEAL) Denmark $1.423B 0.00
Zymeworks (ZYME) Canada $1.382B 0.00
Mesoblast (MESO) Australia $1.379B 0.00
Coherus BioSciences (CHRS) United States $1.351B 7.88
Forma Therapeutics Holdings (FMTX) United States $1.326B 0.00
Intra-Cellular Therapies (ITCI) United States $1.302B 0.00
Epizyme (EPZM) United States $1.293B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
NGM Biopharmaceuticals (NGM) United States $1.261B 0.00
Mersana Therapeutics (MRSN) United States $1.244B 0.00
REGENXBIO (RGNX) United States $1.215B 0.00
Adverum Biotechnologies (ADVM) United States $1.202B 0.00
Compugen (CGEN) Israel $1.201B 0.00
Intellia Therapeutics (NTLA) United States $1.199B 0.00
Akcea Therapeutics (AKCA) United States $1.158B 0.00
Alcobra (ARCT) United States $1.153B 0.00
Beam Therapeutics (BEAM) United States $1.147B 0.00
Arcus Biosciences (RCUS) United States $1.139B 0.00
Arvinas (ARVN) United States $1.084B 0.00
Alector (ALEC) United States $1.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.029B 0.00
NantKwest (NK) United States $1.005B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.976B 0.00
Myriad Genetics (MYGN) United States $0.974B 50.27
Heska (HSKA) United States $0.965B 0.00
Athenex (ATNX) United States $0.949B 0.00
Retrophin (RTRX) United States $0.937B 0.00
Morphic Holding (MORF) United States $0.858B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.838B 0.00
Castle Biosciences (CSTL) United States $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Pharming Group (PHGUF) Netherlands $0.807B 18.43
Cara Therapeutics (CARA) United States $0.798B 0.00
Codexis (CDXS) United States $0.791B 0.00
Dynavax Technologies (DVAX) United States $0.755B 0.00
Intrexon (PGEN) United States $0.748B 0.00
Frequency Therapeutics (FREQ) United States $0.719B 0.00
Cellectis S.A (CLLS) France $0.713B 0.00
Vericel (VCEL) United States $0.711B 0.00
Kadmon Holdings (KDMN) United States $0.710B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.695B 0.00
MiMedx (MDXG) United States $0.686B 0.00
Biofrontera AG (BFRA) Germany $0.684B 0.00
Agenus (AGEN) United States $0.653B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.651B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.650B 5.69
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.614B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.586B 0.00
Syros Pharmaceuticals (SYRS) United States $0.554B 0.00
MeiraGTx Holdings (MGTX) United States $0.532B 0.00
Kala Pharmaceuticals (KALA) United States $0.512B 0.00
Anika Therapeutics (ANIK) United States $0.507B 22.16
Prothena (PRTA) Ireland $0.503B 0.00
AnaptysBio (ANAB) United States $0.485B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Innate Pharma S.A (IPHA) France $0.482B 0.00
Cel-Sci (CVM) United States $0.480B 0.00
Protagonist Therapeutics (PTGX) United States $0.467B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.462B 32.68
Aquinox Pharmaceuticals (NLTX) United States $0.460B 0.00
Athersys (ATHX) United States $0.456B 0.00
Avid Bioservices (CDMO) United States $0.455B 0.00
AC Immune SA (ACIU) Switzerland $0.451B 0.00
Pfenex (PFNX) United States $0.442B 0.00
Clovis Oncology (CLVS) United States $0.431B 0.00
Prometic Life Sciences (LMNL) Canada $0.414B 0.00
Scholar Rock Holding (SRRK) United States $0.394B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.394B 0.00
Puma Biotechnology (PBYI) United States $0.394B 0.00
ANI Pharmaceuticals (ANIP) United States $0.390B 9.19
PDL BioPharma (PDLI) United States $0.377B 0.00
Merus (MRUS) Netherlands $0.377B 0.00
Cellular Biomedicine (CBMG) United States $0.374B 0.00
MannKind (MNKD) United States $0.374B 0.00
Albireo Pharma (ALBO) United States $0.367B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.366B 0.00
Kamada (KMDA) Israel $0.358B 17.13
Precision BioSciences (DTIL) United States $0.346B 0.00
WAVE Life Sciences (WVE) Singapore $0.339B 0.00
Geron (GERN) United States $0.333B 0.00
CytomX Therapeutics (CTMX) United States $0.327B 0.00
Trevena (TRVN) United States $0.301B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
ChromaDex (CDXC) United States $0.301B 0.00
IBio (IBIO) United States $0.290B 0.00
Arbutus Biopharma (ABUS) United States $0.288B 0.00
OSMOTICA PHARM (OSMT) United States $0.284B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
Selecta Biosciences (SELB) United States $0.277B 0.00
Starpharma Holdings (SPHRY) Australia $0.271B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Menlo Therapeutics (MNLO) United States $0.267B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Verastem (VSTM) United States $0.261B 0.00
NextCure (NXTC) United States $0.261B 0.00
Affimed (AFMD) Germany $0.255B 0.00
DBV Technologies S.A (DBVT) France $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.251B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Dyadic (DYAI) United States $0.241B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Northwest Biotherapeutics (NWBO) United States $0.233B 0.00
Celldex Therapeutics (CLDX) United States $0.230B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
Pluristem Therapeutics (PSTI) Israel $0.223B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Sutro Biopharma (STRO) United States $0.207B 0.00
Exicure (XCUR) United States $0.200B 0.00
Aduro Biotech (ADRO) United States $0.200B 0.00
XOMA (XOMA) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.199B 9.30
Nymox Pharmaceutical (NYMX) Canada $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.193B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Cyclerion Therapeutics (CYCN) United States $0.179B 0.00
Aptinyx (APTX) United States $0.176B 0.00
Five Prime Therapeutics (FPRX) United States $0.175B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.170B 0.00
VTv Therapeutics (VTVT) United States $0.169B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
Aytu Bioscience (AYTU) United States $0.158B 0.00
Bellus Health (BLU) Canada $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.155B 0.00
TELA Bio (TELA) United States $0.150B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
VolitionRX (VNRX) United States $0.139B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.137B 0.00
Gritstone Oncology (GRTS) United States $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.129B 0.00
Cardiff Oncology (CRDF) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 6.45
Palatin Technologies (PTN) United States $0.127B 3.25
Lumos Pharma (LUMO) United States $0.125B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
CorMedix Inc (CRMD) United States $0.124B 0.00
Protalix BioTherapeutics (PLX) Israel $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.120B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.118B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Windtree Therapeutics (WINT) United States $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.104B 0.00
Antibe Therapeutics (ATBPF) Canada $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.090B 0.00
Organovo Holdings (ONVO) United States $0.090B 0.00
AquaBounty Technologies (AQB) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
AnPac Bio-Medical Science (ANPC) China $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
DiaMedica Therapeutics (DMAC) United States $0.075B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.064B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 90.00
Aerpio Pharmaceuticals (ARPO) United States $0.062B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
Genetic Technologies (GENE) Australia $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
Novogen (KZIA) Australia $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Spherix (AIKI) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Chanticleer Holdings (SONN) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00